Expanded Access for LJPC-501
NCT03245528 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS
Last updated 2018-03-08
Summary
The primary objective of the study is to provide access to LJPC-501 for distributive shock patients who remain hypotensive despite receiving fluid and vasopressor therapy.
Conditions
- Catecholamine Resistant Hypotension (CRH)
- Distributive Shock
- High Output Shock
- Sepsis
- Vasodilatory Shock
Interventions
- DRUG
-
LJPC-501
angiotensin II
Sponsors & Collaborators
-
La Jolla Pharmaceutical Company
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
RApid Fluid Volume EXpansion in Patients in Shock After the Initial Phase of Resuscitation.
NCT02645851 ·Status: TERMINATED ·Phase: NA
-
Use of a Mini-fluid Bolus to Identify Fluid Responsiveness
NCT03058653 ·Status: WITHDRAWN ·Phase: NA
-
Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Cardiogenic Shock
NCT04642768 ·Status: COMPLETED ·Phase: NA
-
Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma
NCT01411852 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal VAsopressor titraTION Pilot Randomized Controlled Trial
NCT01800877 ·Status: COMPLETED ·Phase: NA
-
Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension
NCT01271114 ·Status: TERMINATED ·Phase: PHASE3
-
HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled Trial
NCT04391231 ·Status: WITHDRAWN ·Phase: PHASE4
-
Esophageal Echo Assessment of LV Function During Acute Normovolemic Hemodilution Using Crystalloid or Hypertonic Saline
NCT00683007 ·Status: COMPLETED ·Phase: NA
-
Hypertonic Resuscitation Following Traumatic Injury
NCT00316017 ·Status: TERMINATED ·Phase: PHASE3
-
Small Volume Fluid Challenge as a Predictor of Fluid Responsiveness in Patients With Circulatory Failure
NCT03622099 ·Status: COMPLETED
-
Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)
NCT01128413 ·Status: TERMINATED ·Phase: NA
-
Low Dose Vasopressin in Traumatic Shock
NCT00420407 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
NCT05232838 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Levosimendan for Veno-arterial ECMO Weaning
NCT04323709 ·Status: COMPLETED
-
ICU Norepinephrine Load
NCT05032261 ·Status: COMPLETED
-
Impact of Starting Dose of Vasopressor on Hemodynamic Response in Shock
NCT06481839 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Calfactant for Direct Acute Respiratory Distress Syndrome
NCT00682500 ·Status: TERMINATED ·Phase: PHASE3
-
VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility
NCT04089098 ·Status: COMPLETED
-
Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension
NCT02462902 ·Status: COMPLETED ·Phase: NA
-
Continuous Passive Paracentesis for Intra-abdominal Hypertension
NCT04322201 ·Status: UNKNOWN ·Phase: NA
-
Time Course Evolution of Cardiac Output
NCT03694717 ·Status: COMPLETED
-
Treatment of Hyperlactatemia in Acute Circulatory Failure Based on Analysis of CO2: a Prospective Randomized Superiority Study (The LACTEL Study)
NCT05032521 ·Status: COMPLETED ·Phase: PHASE4
-
Variation in Fluids Administered in Shock
NCT03190408 ·Status: COMPLETED
-
Fluid Responsiveness Evaluation in Sepsis-associated Hypotension
NCT02837731 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock
NCT01433276 ·Status: COMPLETED ·Phase: PHASE3